Search results
Syros Pharmaceuticals, Inc. (SYRS) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance· 2 years agoSyros Pharmaceuticals, Inc. (SYRS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing...
Syros Pharmaceuticals (SYRS) Soars 22.2%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 2 months agoSyros Pharmaceuticals (SYRS) saw its shares surge in the last session with trading volume being...
Syros Pharmaceuticals, Inc. (SYRS) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks via Yahoo Finance· 5 months agoSyros Pharmaceuticals, Inc. (SYRS) could be a great choice for investors looking to make a profit...
Syros (SYRS) Stock Surges 200% in 3 Months: Here's Why
Zacks via Yahoo Finance· 5 months agoSyros Pharmaceuticals, Inc. SYRS shares have skyrocketed 200% in the past three months compared with...
Are You Looking for a Top Momentum Pick? Why Syros Pharmaceuticals, Inc. (SYRS) is a Great Choice
Zacks via Yahoo Finance· 5 months agoMomentum investing revolves around the idea of following a stock's recent trend in either direction....
Investors in Syros Pharmaceuticals (NASDAQ:SYRS) have seen respectable returns of 99% over the past...
Simply Wall St. via Yahoo Finance· 3 months agoThese days it's easy to simply buy an index fund, and your returns should (roughly) match the...
Syros Pharmaceuticals, Inc. (SYRS) Reports Q3 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 years agoSyros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of 38.36% and 21.65%,...
One Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) insider upped their stake by 212% in the previous year
Simply Wall St. via Yahoo Finance· 1 year agoViewing insider transactions for Syros Pharmaceuticals, Inc.'s (NASDAQ:SYRS ) over the last year, we...
Analysts Estimate Syros Pharmaceuticals, Inc. (SYRS) to Report a Decline in Earnings: What to Look...
Zacks via Yahoo Finance· 1 month agoSyros Pharmaceuticals (SYRS) doesn't possess the right combination of the two key ingredients for a...
Syros (SYRS) Up on FDA's Orphan Tag for Pancreatic Cancer Drug
Zacks via Yahoo Finance· 2 years agoSyros Pharmaceuticals (SYRS) receives Orphan Drug designation from the FDA for its pipeline...